Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks.
Journal
Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
18
10
2022
accepted:
06
03
2023
revised:
01
03
2023
medline:
8
5
2023
pubmed:
23
3
2023
entrez:
22
3
2023
Statut:
ppublish
Résumé
Muscle-invasive bladder cancer (BLCA) is an aggressive disease. Consensus BLCA transcriptomic subtypes have been proposed, with two major Luminal and Basal subgroups, presenting distinct molecular and clinical characteristics. However, how these distinct subtypes are regulated remains unclear. We hypothesized that epigenetic activation of distinct super-enhancers could drive the transcriptional programs of BLCA subtypes. Through integrated RNA-sequencing and epigenomic profiling of histone marks in primary tumours, cancer cell lines, and normal human urothelia, we established the first integrated epigenetic map of BLCA and demonstrated the link between subtype and epigenetic control. We identified the repertoire of activated super-enhancers and highlighted Basal, Luminal and Normal-associated SEs. We revealed super-enhancer-regulated networks of candidate master transcription factors for Luminal and Basal subgroups including FOXA1 and ZBED2, respectively. FOXA1 CRISPR-Cas9 mutation triggered a shift from Luminal to Basal phenotype, confirming its role in Luminal identity regulation and induced ZBED2 overexpression. In parallel, we showed that both FOXA1 and ZBED2 play concordant roles in preventing inflammatory response in cancer cells through STAT2 inhibition. Our study furthers the understanding of epigenetic regulation of muscle-invasive BLCA and identifies a co-regulated network of super-enhancers and associated transcription factors providing potential targets for the treatment of this aggressive disease.
Identifiants
pubmed: 36944729
doi: 10.1038/s41388-023-02662-1
pii: 10.1038/s41388-023-02662-1
pmc: PMC10162941
doi:
Substances chimiques
Transcription Factors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1524-1542Informations de copyright
© 2023. The Author(s).
Références
Dev Biol. 2014 Feb 15;386(2):321-30
pubmed: 24374157
Nat Rev Cancer. 2018 Nov;18(11):696-705
pubmed: 30293088
J Pathol. 2017 May;242(1):113-125
pubmed: 28195647
Cell. 2013 Apr 11;153(2):320-34
pubmed: 23582323
Trends Cancer. 2017 Apr;3(4):269-281
pubmed: 28718439
Nature. 2019 Jul;571(7765):413-418
pubmed: 31243372
Nucleic Acids Res. 2017 Jan 4;45(D1):D658-D662
pubmed: 27789702
Sci Transl Med. 2014 Jul 9;6(244):244ra91
pubmed: 25009231
Cancer Cell. 2016 Jul 11;30(1):27-42
pubmed: 27321955
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Nat Commun. 2021 Apr 16;12(1):2301
pubmed: 33863885
BMC Cancer. 2016 Nov 3;16(1):837
pubmed: 27809812
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Genome Med. 2020 May 27;12(1):47
pubmed: 32460812
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Nat Genet. 2017 Sep;49(9):1408-1413
pubmed: 28740262
Nat Cell Biol. 2020 Jun;22(6):701-715
pubmed: 32424275
Cancer Discov. 2018 Jan;8(1):108-125
pubmed: 28963353
Nat Genet. 2016 Aug;48(8):838-47
pubmed: 27322546
Genome Biol. 2014;15(12):550
pubmed: 25516281
Front Genet. 2019 Sep 03;10:775
pubmed: 31552090
Am J Pathol. 2011 Mar;178(3):1350-60
pubmed: 21356385
Eur Urol. 2020 Apr;77(4):420-433
pubmed: 31563503
Genome Biol. 2021 Apr 15;22(1):105
pubmed: 33858483
Nat Commun. 2019 Mar 22;10(1):1333
pubmed: 30902996
Cancer Cell. 2014 Feb 10;25(2):152-65
pubmed: 24525232
Bioinformatics. 2019 Nov 1;35(22):4851-4853
pubmed: 31233103
Cell. 2013 Nov 7;155(4):934-47
pubmed: 24119843
Nat Commun. 2018 May 17;9(1):1978
pubmed: 29773832
Exp Cell Res. 2018 Aug 15;369(2):284-294
pubmed: 29842880
Mol Cell. 2016 Apr 7;62(1):79-91
pubmed: 27058788
Cancer Cell. 2013 Dec 9;24(6):777-90
pubmed: 24332044
J Clin Invest. 2019 Feb 1;129(2):569-582
pubmed: 30511964
Nat Commun. 2019 Sep 25;10(1):4349
pubmed: 31554791
Cell Rep. 2014 Nov 20;9(4):1235-45
pubmed: 25456126
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nature. 2014 Mar 20;507(7492):315-22
pubmed: 24476821
BMC Med Genomics. 2015 May 26;8:25
pubmed: 26008846
Nat Rev Urol. 2014 Jul;11(7):400-10
pubmed: 24960601
Cell. 2013 Apr 11;153(2):307-19
pubmed: 23582322
Sci Rep. 2020 Jul 2;10(1):10952
pubmed: 32616859
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Cell Death Differ. 2017 May;24(5):809-818
pubmed: 28282036
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Nat Rev Genet. 2021 Dec;22(12):749-755
pubmed: 34480110
Genome Med. 2020 Sep 28;12(1):85
pubmed: 32988402
Int J Cancer. 1997 Apr 10;71(2):284-91
pubmed: 9139855
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Biotechnol. 2018 Jun;36(5):421-427
pubmed: 29608177
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11471-11482
pubmed: 32385160
Genes (Basel). 2015 Nov 09;6(4):1183-200
pubmed: 26569311
Bioinformatics. 2016 Jul 15;32(14):2233-5
pubmed: 27153652
Cell. 2017 Oct 19;171(3):540-556.e25
pubmed: 28988769
Neuron. 2017 May 3;94(3):550-568.e10
pubmed: 28472656
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Nat Methods. 2012 Feb 28;9(3):215-6
pubmed: 22373907
J Clin Invest. 2021 Jul 15;131(14):
pubmed: 34101624
Sci Rep. 2018 Feb 27;8(1):3737
pubmed: 29487377
Oncogene. 2013 Jan 31;32(5):554-63
pubmed: 22391567
Nucleic Acids Res. 2019 Jan 8;47(D1):D729-D735
pubmed: 30462313
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Nat Commun. 2016 Sep 28;7:12983
pubmed: 27677335
Oncogenesis. 2019 Nov 26;8(12):69
pubmed: 31772149
Gut. 2023 Feb;72(2):226-241
pubmed: 35817555
Cell. 2017 Aug 24;170(5):875-888.e20
pubmed: 28757253
Genome Res. 2016 Mar;26(3):385-96
pubmed: 26843070
Nature. 2020 Dec;588(7839):664-669
pubmed: 33328632
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Elife. 2018 Nov 26;7:
pubmed: 30475207
J Pathol. 2012 Jul;227(3):315-24
pubmed: 22422578
Nat Commun. 2021 Nov 17;12(1):6636
pubmed: 34789735
Eur Urol. 2016 Jul;70(1):106-119
pubmed: 26996659
Cancer Cell. 2018 Dec 10;34(6):982-995.e7
pubmed: 30503705
Sci Rep. 2016 Dec 07;6:38531
pubmed: 27924948
Nat Struct Mol Biol. 2016 Apr;23(4):349-57
pubmed: 26926434
Science. 2014 Dec 12;346(6215):1373-7
pubmed: 25394790
Cell. 2018 Feb 8;172(4):650-665
pubmed: 29425488
Gut. 2020 Apr;69(4):630-640
pubmed: 31409603